| human | Q5 |
| P496 | ORCID iD | 0000-0001-7135-4410 |
| P1053 | ResearcherID | K-6111-2016 |
| P1153 | Scopus author ID | 25642567000 |
| P108 | employer | University of Bologna | Q131262 |
| Policlinico Sant'Orsola-Malpighi | Q3907279 | ||
| P735 | given name | Piergiorgio | Q3903022 |
| Piergiorgio | Q3903022 | ||
| P106 | occupation | researcher | Q1650915 |
| Q36802059 | A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds? |
| Q41707035 | A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy |
| Q37335720 | Antifungal prophylaxis with posaconazole in patients with acute myeloid leukemia: dose intensification coupled with avoidance of proton pump inhibitors is beneficial in shortening time to effective concentrations |
| Q42719368 | Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus. |
| Q36644695 | Does Critical Illness Change Levofloxacin Pharmacokinetics? |
| Q36396195 | Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: a pharmacokinetics/pharmacodynamics-based approach |
| Q85946467 | Everolimus overexposure in a heart transplant patient receiving clarithromycin for the treatment of pneumonia |
| Q57150325 | Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis |
| Q44455948 | Levofloxacin dosing regimen in severely morbidly obese patients (BMI ≥40 kg/m(2)) should be guided by creatinine clearance estimates based on ideal body weight and optimized by therapeutic drug monitoring. |
| Q44123492 | Linezolid underexposure in a patient co-treated with venlafaxine. |
| Q40035394 | Might isoniazid plasma exposure be a valuable predictor of drug-related hepatotoxicity risk among adult patients with TB? |
| Q46350689 | Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient. |
| Q41757518 | Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation. |
| Q41349399 | Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial in |
| Q35960828 | Pharmacokinetics and pharmacodynamics of continuous-infusion meropenem in pediatric hematopoietic stem cell transplant patients |
| Q89209517 | Polytherapy and the risk of potentially inappropriate prescriptions (PIPs) among elderly and very elderly patients in three different settings (hospital, community, long-term care facilities) of the Friuli Venezia Giulia region, Italy: are the very |
| Q98619410 | Population Pharmacokinetics of Continuous-Infusion Meropenem in Febrile Neutropenic Patients with Hematologic Malignancies: Dosing Strategies for Optimizing Empirical Treatment against Enterobacterales and P. aeruginosa |
| Q57518396 | Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp |
| Q43949662 | Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients. |
| Q87459116 | Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperatures |
| Q54574842 | TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient. |
| Q33401050 | Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients. |
| Q34290110 | Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis. |
| Q54402133 | Treatment of consecutive episodes of multidrug-resistant bacterial pleurisy with different aetiology in a heart transplant candidate: proof of concept of pharmacokinetic/pharmacodynamic optimisation of antimicrobial therapy at the infection site. |
| Q43224167 | Validation of limited sampling strategy for estimation of mycophenolic acid exposure during the first year after heart transplantation. |
| Q40317932 | Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers |
Search more.